B

BreezeBio

CRISPR gene therapies delivered by nanoparticles

Research Specialist/Scientist - PK Bioanalytical Assays

Translational Research & Bench BiologyConfirmed live in the last 24 hours
Full-timeBrisbane, CA, USANo salary listedIn-person

About the Job

Requirements

  • Ph.D. or equivalent in Pharmacology, Toxicology, Immunology, Molecular Biology, or a related life science field, with 0–2 years of relevant biotech/pharma industry or postdoctoral experience.
  • Hands-on experience with quantitative bioanalytical assay platforms, including reverse transcription quantitative polymerase chain reaction, enzyme-linked immunosorbent assay, and Meso Scale Discovery, in complex biological matrices such as serum, plasma, and tissue homogenates.
  • Experience working with emerging therapeutic modalities, including gene therapy and nucleic acid therapeutics such as messenger RNA, antisense oligonucleotides, and small interfering RNA.
  • Hands-on experience with pharmacodynamic and immune-monitoring assays integrated with pharmacokinetic sampling, including multicolor flow cytometry, functional assays, and cytokine multiplex profiling.
  • Proficiency with relevant data analysis software such as GraphPad Prism, FlowJo, and Phoenix WinNonlin, and with electronic laboratory notebook and laboratory information management system platforms.
  • Strong written and verbal communication skills, with the ability to present data clearly to cross-functional teams.
  • Work authorization in the United States is required.

Responsibilities

  • Develop, optimize, and independently execute quantitative bioanalytical assays, including reverse transcription quantitative polymerase chain reaction, enzyme-linked immunosorbent assay, and Meso Scale Discovery, to quantify nucleic acid payload and protein analytes in complex biological matrices supporting pharmacokinetic, biodistribution, and toxicokinetic evaluations.
  • Contribute to the design, protocol development, and execution of in vivo downstream assays for pharmacokinetic, biodistribution, pharmacodynamic, and toxicology studies in rodent and other preclinical models supporting investigational new drug-enabling programs.
  • Support pharmacodynamic assays integrated with pharmacokinetic sample collection, including multicolor flow cytometry-based immune cell phenotyping, interferon-gamma enzyme-linked immunospot or FluoroSpot assays, regulatory T-cell suppression assays, and cytokine multiplex profiling using Meso Scale Discovery and bead-based cytokine assay platforms.
  • Support bioanalytical method development, qualification, and troubleshooting in alignment with regulatory bioanalytical expectations; maintain assay robustness, reproducibility, and documentation for regulatory submissions.
  • Independently analyze, interpret, and summarize pharmacokinetic, biodistribution, and pharmacodynamic data, including non-compartmental pharmacokinetic parameters, tissue distribution profiles, and immune modulation endpoints; present results at team, cross-functional, and external meetings.
  • Interact significantly with the Discovery Biology team to develop pharmacodynamic and immune-monitoring assays.
  • Work cooperatively with peers across in vivo and formulation functions in a matrixed laboratory environment, and maintain detailed, organized laboratory records and electronic laboratory notebook entries.

Desired Qualifications

  • Experience with messenger RNA-lipid nanoparticle biodistribution assays or other nucleic acid-based pharmacokinetic assays, such as quantification of messenger RNA or lipid nanoparticle payload in tissues and antisense oligonucleotide or small interfering RNA pharmacokinetics.
  • Familiarity with bioanalytical method development and qualification principles consistent with Food and Drug Administration and International Council for Harmonisation bioanalytical method validation guidance.
  • A successful track record of independent bench execution, rigorous data analysis, and teamwork in a fast-paced biotech environment.
  • Experience collaborating across functional groups and with external partners such as contract research organizations and academic collaborators.

About the Company

BreezeBio

CRISPR gene therapies delivered by nanoparticles

BreezeBio develops and commercializes gene therapies and gene-editing solutions by building a CRISPR delivery system from engineered CRISPR components and a proprietary polymer nanoparticle library. Its product works by packaging Cas9 and guide RNAs into polymer nanoparticles that deliver edits to specific tissues, aiming for safer and more efficient gene knockout therapies. The company differentiates itself with an in-house, proprietary nanoparticle library combined with component-level CRISPR engineering to tailor delivery, supported by proof-of-concept data and ongoing partnerships and licenses. Its goal is to bring gene therapies to the market through licensing, partnering, and direct sales of the delivery technology and resulting therapeutics to medical and healthcare customers.

Company size
51-200
Company stage
Series B
Total funding
$118.5M
Headquarters
Brisbane, CA
Founded
2016

Recently Posted Jobs

Explore more opportunities at BreezeBio

See more jobs